[Clinical results and the distribution of Paramidin to the blood and paranasal mucous membrane after oral administration].
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000378:metabolism* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D009092:Mucous Membrane / Q000378:metabolism; D010256:Paranasal Sinuses / Q000378:metabolism*; D011743:Pyrimidines / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use*; D012852:Sinusitis / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D011743:Pyrimidines